vs
Side-by-side financial comparison of BGSF, INC. (BGSF) and ENANTA PHARMACEUTICALS INC (ENTA). Click either name above to swap in a different company.
BGSF, INC. is the larger business by last-quarter revenue ($22.0M vs $18.6M, roughly 1.2× ENANTA PHARMACEUTICALS INC). BGSF, INC. runs the higher net margin — -5.3% vs -64.1%, a 58.9% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -9.4%). BGSF, INC. produced more free cash flow last quarter ($1.7M vs $-11.8M). Over the past eight quarters, ENANTA PHARMACEUTICALS INC's revenue compounded faster (4.5% CAGR vs -5.3%).
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
BGSF vs ENTA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $22.0M | $18.6M |
| Net Profit | $-1.2M | $-11.9M |
| Gross Margin | 35.0% | — |
| Operating Margin | -17.6% | -60.5% |
| Net Margin | -5.3% | -64.1% |
| Revenue YoY | -9.4% | 9.8% |
| Net Profit YoY | -18.2% | 46.4% |
| EPS (diluted) | $-0.12 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.0M | $18.6M | ||
| Q3 25 | $26.9M | $15.1M | ||
| Q2 25 | $23.5M | $18.3M | ||
| Q1 25 | $20.9M | $14.9M | ||
| Q4 24 | $24.3M | $17.0M | ||
| Q3 24 | $29.8M | $14.6M | ||
| Q2 24 | $25.7M | $18.0M | ||
| Q1 24 | $24.5M | $17.1M |
| Q4 25 | $-1.2M | $-11.9M | ||
| Q3 25 | $-5.8M | $-18.7M | ||
| Q2 25 | $-3.7M | $-18.3M | ||
| Q1 25 | $-722.0K | $-22.6M | ||
| Q4 24 | $-981.0K | $-22.3M | ||
| Q3 24 | $-804.0K | $-28.8M | ||
| Q2 24 | $-761.0K | $-22.7M | ||
| Q1 24 | $-792.0K | $-31.2M |
| Q4 25 | 35.0% | — | ||
| Q3 25 | 35.9% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 36.2% | — | ||
| Q4 24 | 35.9% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 37.3% | — | ||
| Q1 24 | 38.1% | — |
| Q4 25 | -17.6% | -60.5% | ||
| Q3 25 | -3.5% | -121.6% | ||
| Q2 25 | -18.8% | -103.2% | ||
| Q1 25 | 1.6% | -164.3% | ||
| Q4 24 | -15.7% | -138.8% | ||
| Q3 24 | -3.4% | -204.4% | ||
| Q2 24 | -5.7% | -134.6% | ||
| Q1 24 | 1.7% | -192.1% |
| Q4 25 | -5.3% | -64.1% | ||
| Q3 25 | -21.6% | -123.6% | ||
| Q2 25 | -15.9% | -99.7% | ||
| Q1 25 | -3.5% | -151.7% | ||
| Q4 24 | -4.0% | -131.4% | ||
| Q3 24 | -2.7% | -197.3% | ||
| Q2 24 | -3.0% | -126.1% | ||
| Q1 24 | -3.2% | -182.7% |
| Q4 25 | $-0.12 | $-0.42 | ||
| Q3 25 | $-0.52 | $-0.88 | ||
| Q2 25 | $-0.34 | $-0.85 | ||
| Q1 25 | $-0.06 | $-1.06 | ||
| Q4 24 | — | $-1.05 | ||
| Q3 24 | $-0.07 | $-1.36 | ||
| Q2 24 | $-0.07 | $-1.07 | ||
| Q1 24 | — | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $37.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.1M | $126.6M |
| Total Assets | $57.8M | $329.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $37.4M | ||
| Q3 25 | $41.2M | $32.3M | ||
| Q2 25 | $2.8M | $44.8M | ||
| Q1 25 | $2.0M | $60.2M | ||
| Q4 24 | $32.0K | $84.3M | ||
| Q3 24 | $262 | $37.2M | ||
| Q2 24 | $226 | $35.8M | ||
| Q1 24 | $50 | $63.5M |
| Q4 25 | $48.1M | $126.6M | ||
| Q3 25 | $50.7M | $64.7M | ||
| Q2 25 | $78.3M | $79.3M | ||
| Q1 25 | $81.8M | $93.5M | ||
| Q4 24 | $82.3M | $111.8M | ||
| Q3 24 | $82.9M | $128.8M | ||
| Q2 24 | $83.2M | $148.9M | ||
| Q1 24 | $83.6M | $166.1M |
| Q4 25 | $57.8M | $329.5M | ||
| Q3 25 | $83.6M | $280.7M | ||
| Q2 25 | $149.7M | $301.0M | ||
| Q1 25 | $152.3M | $323.0M | ||
| Q4 24 | $150.1M | $348.6M | ||
| Q3 24 | $157.3K | $376.7M | ||
| Q2 24 | $159.8K | $398.8M | ||
| Q1 24 | $170.6K | $413.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $-11.7M |
| Free Cash FlowOCF − Capex | $1.7M | $-11.8M |
| FCF MarginFCF / Revenue | 7.6% | -63.6% |
| Capex IntensityCapex / Revenue | 0.1% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0K | $-18.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $-11.7M | ||
| Q3 25 | $-4.8M | $-6.5M | ||
| Q2 25 | $2.2M | $17.5M | ||
| Q1 25 | $1.1M | $-13.5M | ||
| Q4 24 | $3.2M | $-16.8M | ||
| Q3 24 | $6.5M | $-10.4M | ||
| Q2 24 | $7.3M | $-14.8M | ||
| Q1 24 | $7.4M | $-28.6M |
| Q4 25 | $1.7M | $-11.8M | ||
| Q3 25 | $-4.9M | $-7.9M | ||
| Q2 25 | $2.1M | $17.4M | ||
| Q1 25 | $1.0M | $-16.0M | ||
| Q4 24 | $2.5M | $-25.5M | ||
| Q3 24 | $6.5M | $-19.4M | ||
| Q2 24 | $7.3M | $-21.3M | ||
| Q1 24 | $6.9M | $-30.3M |
| Q4 25 | 7.6% | -63.6% | ||
| Q3 25 | -18.1% | -52.5% | ||
| Q2 25 | 9.1% | 94.7% | ||
| Q1 25 | 5.0% | -107.4% | ||
| Q4 24 | 10.2% | -150.6% | ||
| Q3 24 | 21.7% | -132.5% | ||
| Q2 24 | 28.5% | -118.6% | ||
| Q1 24 | 28.1% | -177.5% |
| Q4 25 | 0.1% | 0.8% | ||
| Q3 25 | 0.4% | 9.6% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.1% | 17.0% | ||
| Q4 24 | 3.0% | 51.6% | ||
| Q3 24 | 0.0% | 61.3% | ||
| Q2 24 | 0.0% | 36.4% | ||
| Q1 24 | 2.0% | 9.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
ENTA
Segment breakdown not available.
